Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-8471117

  • Global Angiography Device Market Research Report Insights, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • Publish: November 2017 | Report Code: HME-8471117

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Angiography devices are used in medical imaging techniques to visualize inside, or lumen of blood vessels and organs of the body with particular interest in the veins, arteries and the heart chambers. . OBRC analysis estimates that the global angiography device market is anticipated to rise at a CAGR of 4.6% during forecasted period 2016-2023. The key trend which is positively influencing the growth of Angiography device market is a gradual shift towards the magnetic resonance imaging from conventional x-ray angiography for diagnostics. Further, some of the prominent drivers of angiography device market are rising geriatric population, rising incidences of cardiovascular diseases and rising awareness programs related to cardiovascular diseases, conferences likely to propel the angiography device market. However, the key restraint those are affecting the market growth are lack of reimbursement and regulatory procedures to limit the growth of angiography devices market.

The global angiography device market is mainly driven by rising occurrence of cardiovascular diseases. According to the Organization for Economic Co-operation (OECD), in 2015, Germany ranked eighth place for high rate of cardiovascular diseases. In Germany, more than 310 people of every 100,000 die from cardiovascular diseases every year. Moreover, as per the World Health Organization (WHO), in 2015, around 7.4 million died due to coronary heart disease. Hence, rising incidences of cardiovascular diseases will generate the demand for angiography devices. Hence, rising incidences of cardiovascular diseases drives the global angiography device market across the globe.

Source: OBRC analysis

The report on global angiography device market is classified on the basis of application, product, technology, procedure, indication and end-users.

Based on technology segment, the market is further classified into:

  • X-ray Angiography
  • Ct Angiography
  • MR Angiography




Based on product segment, the market is further classified into:

  • Catheters Tube
  • Angiography System
  • Balloons
  • Guide wires
  • Vascular closure devices
  • Contrast media  
  • Accessories








Based on application segment, the market is further classified into:

  • Diagnostic
  • Therapeutic



Based on indication segment, the market is further classified into:

  • Valvular heart disease
  • Known/ suspected Cad
  • Congestive Heart Failure
  • Congential Heart Disease
  • Others






Based on procedure segment, the market is further classified into:

  • Micro-Angiography
  • Non -Coronary angiography
  • Coronary Angiography
  • Other Procedures





Based on end-user segment, the market is further classified into:

  • Hospitals
  • Diagnostic Centres
  • Academic Research Laboratories




The revenue for the above application and end-user vertical segments are specific to the angiography market. However, the total revenue of these application and end-user verticals in general has been excluded from the scope of the report.

The global angiography device market has been geographically segmented into:

  • North America (US & Canada)
  • Asia Pacific (China, India, Japan, Australia, Rest of Asia Pacific)
  • Europe (UK, France, Germany, Rest of Europe)
  • Rest of the World (RoW)





Geographically, North America dominates the global angiography device market due to technological advancements and innovation in the healthcare industry. However, Asia-Pacific is considered to be the fastest growing region during the forecasted period owing to increasing procedure volumes of cardiovascular diseases. Countries like India, China, and Brazil mainly lead the market growth, owing to rising investments by public & private sectors to deliver improved healthcare services in these countries, the increase in patient population, and rising  focus of leading players on capturing growth opportunities in these markets.

The angiography devices market is mainly classified on the basis of products, technology, indication application, procedure and end users. On the basis of products, angiography device market is sub segmented into guide-wires, catheters, angiography systems, accessories, balloons, contrast media and vascular closure devices. Based on the technology, the market is sub segmented as magnetic resonance angiography, computed tomography and X-ray of which X-ray segment dominates the market, due to wide applicability in various segments such as veterinary, dental, security, medical and industrial. Further, MRI & CT technologies are anticipated to rise over the forecast period due to shifting preferences from X-ray angiography. On the basis of applications, the market is sub divided into therapeutic and diagnostics. On the basis of indication, the market is sub divided into valvular heart disease, known/suspected CAD, congenital heart failure and congenital heart disease. On the basis of procedure, the angiography device market is further segmented as post-mortem CT angiography, neuro-vascular, coronary angiography, micro-angiography, peripheral angiography, and other procedures. On the other hand, the market is categorised by end users, is subdivided into academic research laboratories, hospitals and diagnostic centres.

Some of the leading market players within global angiography device market are:

  • Siemens Healthcare (Germany)
  • GE Healthcare (U.K)
  • Toshiba Medical System Corporation (Japan)
  • Royal Philips Electronics (Netherlands)
  • Abbott Vascular (U.S)
  • St. Jude Medical Inc. (U.S)
  • Shimadzu Corporation (Japan)
  • Others









Merger & acquisition, partnership, collaboration and product launch are some of the strategies used by companies within global angiography device market. Of these, collaboration, and merger & acquisition are primary strategies adopted by companies for increasing their market share.

For example:  On 31 July 2016, GE Healthcare has acquired Biosafe Group SA. This acquisition of Biosafe expands the market for GE Healthcare’s services and solutions for cell therapy customers, end-to-end medical products and further it expands GE’s technology reach to a number of new cell and therapy types.

Company profiling showcased within global angiography device market offers detailed analysis on company’s product portfolio, strategic initiatives, competitive landscape, market share and SCOT analysis.

Key reasons to buy the report:

  • The report includes market estimation forecast and analysis during forecast period 2016-2023.
  • The report points out scenarios that can drive, challenge, and restraint global angiography device market.
  • Company profiling within the report offers strategic initiatives, and market share analysis of major players within the market.
  • The report offers snapshot on recent regulatory and government policies impacting market growth for the forecasted period.





How we are different from others:

At OBRC, our reports offer an extensive portfolio through completed market analysis along with market share, market size, and market segmentation. The DROC for the markets are well thought out and researched after consulting with industry experts. Global angiography device market showcases market analysis through models like investment vs. adoption, see saw analysis, and so on. The report also provides overview on product application, adoption and decision support within each segment. The company profiling for each major players within the market is showcased via SCOT analysis.

Key findings of global angiography device market:

  • Rising incidences of cardiovascular diseases is fuelling the growth of global angiography device market.
  • North America is anticipated to hold highest revenue share in 2016.
  • Asia-Pacific is the fastest growing market.
  • X-ray segment dominates the market.
  • Acquisition is the key strategy adopted by various market players of global angiography device market.






 

1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL ANGIOGRAPHY DEVICE MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION & SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATOR FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES & ANALYSIS
2.8.2. MARKET SHARE & TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. AGING POPULATION 
3.1.2. RISING PREVALENCE OF  CARDIOVASCULAR DISEASE
 
3.1.3. RISE IN AWARENESS PROGRAMS AND CONFERENCES 
3.1.4. GOVERNMENT INVESTMENTS 
3.1.5.
3.2. MARKET RESTRAINTS
3.2.1. LACK OF REIMBURSEMENT
3.2.2. HIGH COST INVOLVED IN ANGIOGRAPHY TECHNIQUES  
3.3. MARKET OPPORTUNITIES
3.3.1. RISING INVESTMENT POTENTIAL IN IMMATURE EMERGING MARKET
3.3.2. RISING  TECHNOLOGICAL ADVANACEMENTS 
3.4.   MARKET CHALLENGES 
3.4.1. HIGH COST OF DIGITAL ANGIOGRAPHY DEVICES AND INSTRUMENTS
3.4.2. PRODUCT RECALLS 
 
4. MARKET SEGMENTATION 
4.1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL X-RAY ANGIOGRAPHY MARKET
4.1.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.1.5.1.3. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.4. KEY CONCLUSIONS
4.1.5.2. GLOBAL CT ANGIOGRAPHY MARKET
4.1.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.1.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.2.4. KEY CONCLUSIONS
4.1.5.3. GLOBAL  MR ANGIOGRAPHY MARKET
4.1.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.1.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.1.5.3.4. KEY CONCLUSIONS
4.2. GLOBAL ANGIOGRAPHY DEVICE MARKET BY PRODUCTS 2014-2023 ($ MILLION)
4.2.1.1.1. MARKET DEFINITION AND SCOPE
4.2.1.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.1.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.1.1.4. OPPORTUNITY MATRIX
4.2.1.1.5. MARKET SEGMENTATION
4.2.1.2. GLOBAL ANGIOGRAPHY SYSTEM MARKET
4.2.1.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.1.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.1.2.3. KEY PLAYERS & KEY PRODUCTS 
4.2.1.2.4. KEY CONCLUSIONS
4.2.1.3. GLOBAL  CATHETERS TUBE MARKET
4.2.1.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.1.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.1.3.3. KEY PLAYERS & KEY PRODUCTS 
4.2.1.3.4. KEY CONCLUSIONS
4.2.1.4. GLOBAL GUIDE-WIRES MARKET
4.2.1.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.1.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.1.4.3. KEY PLAYERS & KEY PRODUCTS 
4.2.1.4.4. KEY CONCLUSIONS
4.2.1.5. GLOBAL BALLOONS MARKET
4.2.1.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.1.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.1.5.3. KEY PLAYERS & KEY PRODUCTS 
4.2.1.5.4. KEY CONCLUSIONS
4.2.1.6. GLOBAL CONTRAST MEDIA  MARKET
4.2.1.6.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.1.6.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.1.6.3. KEY PLAYERS & KEY PRODUCTS 
4.2.1.6.4. KEY CONCLUSIONS
4.2.1.7. GLOBAL VASCULAR CLOSURE DEVICES MARKET
4.2.1.7.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.1.7.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.1.7.3. KEY PLAYERS & KEY PRODUCTS 
4.2.1.7.4. KEY CONCLUSIONS
4.2.1.8. GLOBAL ACCESSORIES MARKET
4.2.1.8.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.1.8.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.2.1.8.3. KEY PLAYERS & KEY PRODUCTS 
4.2.1.8.4. KEY CONCLUSIONS
4.3. GLOBAL ANGIOGRAPHY DEVICE MARKET BY APPLICATION 2014-2023 ($ MILLION)
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL   DIAGNOSTIC  MARKET
4.3.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.3.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.1.4. KEY CONCLUSIONS
4.3.5.2. GLOBAL   THERAPEUTIC  MARKET
4.3.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.3.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.3.5.2.4. KEY CONCLUSIONS
 
4.4. GLOBAL ANGIOGRAPHY DEVICE MARKETBY  PROCEDURE 2014-2023 ($ MILLION)
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL CORONARY ANGIOGRAPHY DEVICE MARKET
4.4.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.4.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.1.4. KEY CONCLUSIONS
4.4.5.2. GLOBAL  MICRO-ANGIOGRAPHY  MARKET
4.4.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.4.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.2.4. KEY CONCLUSIONS
4.4.5.3. GLOBAL NON-CORONARY ANGIOGRAPHY MARKET
4.4.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.4.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.3.4. KEY CONCLUSIONS
4.4.5.4. GLOBAL OTHER PROCEDURES MARKET
4.4.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.4.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.4.5.4.4. KEY CONCLUSIONS
4.5. GLOBAL ANGIOGRAPHY DEVICE MARKET BY  INDICATION 2014-2023 ($ MILLION)
4.5.1. MARKET DEFINITION AND SCOPE
4.5.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.5.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.5.4. OPPORTUNITY MATRIX
4.5.5. MARKET SEGMENTATION 
4.5.5.1. GLOBAL KNOWN/SUSPECTED CAD  MARKET
4.5.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.5.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.5.5.1.4. KEY CONCLUSIONS
4.5.5.2. GLOBAL VALVULAR HEART DISEASE MARKET
4.5.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.5.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.5.5.2.4. KEY CONCLUSIONS
4.5.5.3. GLOBAL  CONGENITAL HEART DISEASE MARKET
4.5.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.5.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.5.5.3.4. KEY CONCLUSIONS
4.5.5.4. GLOBAL  CONGESTIVE HEART FAILURE MARKET
4.5.5.4.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.4.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.5.5.4.3. KEY PLAYERS & KEY PRODUCTS 
4.5.5.4.4. KEY CONCLUSIONS
4.5.5.5. GLOBAL  OTHERS  MARKET
4.5.5.5.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.5.5.5.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.5.5.5.3. KEY  PLAYERS & KEY PRODUCTS 
4.5.5.5.4. KEY CONCLUSIONS
4.6. GLOBAL ANGIOGRAPHY DEVICE MARKET BY  END-USERS 2014-2023 ($ MILLION)
4.6.1. MARKET DEFINITION AND SCOPE
4.6.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.6.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.6.4. OPPORTUNITY MATRIX
4.6.5. MARKET SEGMENTATION 
4.6.5.1. GLOBAL   HOSPITALS MARKET
4.6.5.1.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.1.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.6.5.1.3. KEY PLAYERS & KEY PRODUCTS 
4.6.5.1.4. KEY CONCLUSIONS
4.6.5.2. GLOBAL   DIAGNOSTIC CENTERS MARKET
4.6.5.2.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.2.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.6.5.2.3. KEY PLAYERS & KEY PRODUCTS 
4.6.5.2.4. KEY CONCLUSIONS
4.6.5.3. GLOBAL   ACADEMIC RESEARCH LABORATORIES MARKET
4.6.5.3.1. ADOPTION SCENARIO & MARKET DETERMINANTS
4.6.5.3.2. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION) 
4.6.5.3.3. KEY PLAYERS & KEY PRODUCTS 
4.6.5.3.4. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGER AND ACQUISITION
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIP
 
6. GEOGRAPHIC ANALYSIS
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GLOBAL ANGIOGRAPHY DEVICE MARKET BY REGION 2014-2023 ($ MILLION)
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. REST OF EUROPE
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. AUSTRALIA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. REST OF ASIA PACIFIC
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. . ABBOTT VASCULAR (UNITED STATES)
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.1.5. STRATEGIC ANALYSIS
 
7.2. BOSTON SCIENTIFIC CORPORATION (UNITED STATES)
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS
7.2.5. STRATEGIC ANALYSIS
 
7.3. CARESTREAM HEALTH (UNITED STATES)
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.3.5. STRATEGIC ANALYSIS
 
7.4. CORDIS CORPORATION (A JNJ COMPANY) (UNITED STATES)
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.4.5. STRATEGIC ANALYSIS
 
7.5. ESAOTE (ITALY)
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.5.5. STRATEGIC ANALYSIS
 
7.6. FUJIFILM HOLDINGS (JAPAN)
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS
7.6.5. STRATEGIC ANALYSIS
 
7.7. GE HEALTHCARE (UNITED KINGDOM)
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS
7.7.5. STRATEGIC ANALYSIS
 
7.8. HITACHI MEDICAL CORPORATION(JAPAN)
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS
7.8.5. STRATEGIC ANALYSIS
 
7.9. HOLOGIC (UNITED STATES)
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS
7.9.5. STRATEGIC ANALYSIS
 
7.10. JUDE MEDICAL (UNITED STATES)
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.10.5. STRATEGIC ANALYSIS
 
7.11. MEDTRONIC INC.(UNITED STATES)
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS
7.11.5. STRATEGIC ANALYSIS
 
7.12. PHILIPS HEALTHCARE (US)
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS
7.12.5. STRATEGIC ANALYSIS
7.13. SHIMADZU CORPORATION ( JAPAN)
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.13.5. STRATEGIC ANALYSIS
7.14. SIEMENS HEALTHCARE (GERMANY)
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS
7.14.5. STRATEGIC ANALYSIS
7.15. TOSHIBA CORPORATION (JAPAN) 
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
7.15.5. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL ANGIOGRAPHY DEVICE MARKET BY TECHNOLOGY 2014-2023 ($ MILLION)
2. GLOBAL X-RAY ANGIOGRAPHY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
3. GLOBAL  CT ANGIOGRAPHY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
4. GLOBAL  MR ANGIOGRAPHY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
5. GLOBAL ANGIOGRAPHY DEVICE MARKET BY PRODUCTS 2014-2023 ($ MILLION)
6. GLOBAL ANGIOGRAPHY SYSTEM MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
7. GLOBAL CATHETERS TUBE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
8. GLOBAL  GUIDE-WIRES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
9. GLOBAL BALLOONS ANGIOGRAPHY DEVICE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
10. GLOBAL CONTRAST MEDIA  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
11. GLOBAL  VASCULAR CLOSURE DEVICES ANGIOGRAPHY DEVICE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
12. GLOBAL  ACCESSORIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
13. GLOBAL ANGIOGRAPHY DEVICE MARKET BY APPLICATION2014-2023 ($ MILLION)
14. GLOBAL  DIAGNOSTIC MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
15. GLOBAL THERAPEUTIC  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. GLOBAL ANGIOGRAPHY DEVICE MARKET BY PROCEDURE2014-2023 ($ MILLION)
17. GLOBAL  CORONARY ANGIOGRAPHY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
18. GLOBAL MICRO-ANGIOGRAPHY  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
19. GLOBAL  NON-CORONARY ANGIOGRAPHY MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
20. GLOBAL  OTHER PROCEDURES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
21. GLOBAL ANGIOGRAPHY DEVICE MARKET BY INDICATION 2014-2023 ($ MILLION)
22. GLOBAL KNOWN/SUSPECTED CAD MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
23. GLOBAL VALVULAR HEART DISEASE MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
24. GLOBAL  CONGENITAL HEART DISEASE  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
25. GLOBAL  CONGESTIVE HEART FAILURE  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
26. GLOBAL  OTHER CONDITIONS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
27. GLOBAL ANGIOGRAPHY DEVICE MARKET BY END-USER 2014-2023 ($ MILLION)
28. GLOBAL HOSPITALS MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
29. GLOBAL DIAGNOSTICS CENTERS  MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
30. GLOBAL ACADEMIC RESEARCH LABORATORIES MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
31. NORTH AMERICA ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
32. EUROPE ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
33. ASIA PACIFIC ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
34. REST OF THE WORLD ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL X-RAY ANGIOGRAPHY MARKET 2014-2023 ($ MILLION)
2. GLOBAL  CT ANGIOGRAPHY MARKET 2014-2023 ($ MILLION)
3. GLOBAL  MR ANGIOGRAPHY MARKET 2014-2023 ($ MILLION)
4. GLOBAL ANGIOGRAPHY SYSTEM MARKET 2014-2023 ($ MILLION)
5. GLOBAL CATHETERS TUBE MARKET 2014-2023 ($ MILLION)
6. GLOBAL  GUIDE-WIRES MARKET 2014-2023 ($ MILLION)
7. GLOBAL BALLOONS ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
8. GLOBAL CONTRAST MEDIA  MARKET 2014-2023 ($ MILLION)
9. GLOBAL  VASCULAR CLOSURE DEVICES ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
10. GLOBAL  ACCESSORIES MARKET 2014-2023 ($ MILLION)
11. GLOBAL  DIAGNOSTIC MARKET 2014-2023 ($ MILLION)
12. GLOBAL THERAPEUTIC  MARKET 2014-2023 ($ MILLION)
13. GLOBAL  CORONARY ANGIOGRAPHY MARKET 2014-2023 ($ MILLION)
14. GLOBAL MICRO-ANGIOGRAPHY  MARKET 2014-2023 ($ MILLION)
15. GLOBAL  NON-CORONARY ANGIOGRAPHY MARKET 2014-2023 ($ MILLION)
16. GLOBAL  OTHER PROCEDURES MARKET 2014-2023 ($ MILLION)
17. GLOBAL KNOWN/SUSPECTED CAD MARKET 2014-2023 ($ MILLION)
18. GLOBAL VALVULAR HEART DISEASE MARKET 2014-2023 ($ MILLION)
19. GLOBAL  CONGENITAL HEART DISEASE  MARKET 2014-2023 ($ MILLION)
20. GLOBAL  CONGESTIVE HEART FAILURE  MARKET 2014-2023 ($ MILLION)
21. GLOBAL  OTHER CONDITIONS MARKET 2014-2023 ($ MILLION)
22. GLOBAL HOSPITALS MARKET 2014-2023 ($ MILLION)
23. GLOBAL DIAGNOSTICS CENTERS  MARKET 2014-2023 ($ MILLION)
24. GLOBAL ACADEMIC RESEARCH LABORATORIES MARKET 2014-2023 ($ MILLION)
25. UNITED STATES (U.S.) ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
26. CANADA ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
27. UNITED KINGDOM (UK) ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
28. FRANCE ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
29. GERMANY ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
30. SPAIN ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
31. ROE ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
32. INDIA ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
33. CHINA ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
34. JAPAN ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
35. AUSTRALIA ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
36. ROAPAC ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
37. LATIN AMERICA ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
38. MENA ANGIOGRAPHY DEVICE MARKET 2014-2023 ($ MILLION)
 

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion